277 related articles for article (PubMed ID: 26838906)
1. Double targeting, controlled release and reversible delivery of daunorubicin to cancer cells by polyvalent aptamers-modified gold nanoparticles.
Taghdisi SM; Danesh NM; Lavaee P; Emrani AS; Hassanabad KY; Ramezani M; Abnous K
Mater Sci Eng C Mater Biol Appl; 2016 Apr; 61():753-61. PubMed ID: 26838906
[TBL] [Abstract][Full Text] [Related]
2. Targeted and controlled release delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer-modified gold nanoparticles.
Danesh NM; Lavaee P; Ramezani M; Abnous K; Taghdisi SM
Int J Pharm; 2015 Jul; 489(1-2):311-7. PubMed ID: 25936625
[TBL] [Abstract][Full Text] [Related]
3. Reversible targeting and controlled release delivery of daunorubicin to cancer cells by aptamer-wrapped carbon nanotubes.
Taghdisi SM; Lavaee P; Ramezani M; Abnous K
Eur J Pharm Biopharm; 2011 Feb; 77(2):200-6. PubMed ID: 21168488
[TBL] [Abstract][Full Text] [Related]
4. Double targeting and aptamer-assisted controlled release delivery of epirubicin to cancer cells by aptamers-based dendrimer in vitro and in vivo.
Taghdisi SM; Danesh NM; Ramezani M; Lavaee P; Jalalian SH; Robati RY; Abnous K
Eur J Pharm Biopharm; 2016 May; 102():152-8. PubMed ID: 26987703
[TBL] [Abstract][Full Text] [Related]
5. Biomedical Applications of DNA-Conjugated Gold Nanoparticles.
Wang CC; Wu SM; Li HW; Chang HT
Chembiochem; 2016 Jun; 17(12):1052-62. PubMed ID: 26864481
[TBL] [Abstract][Full Text] [Related]
6. Targeted delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer.
Taghdisi SM; Abnous K; Mosaffa F; Behravan J
J Drug Target; 2010 May; 18(4):277-81. PubMed ID: 19943768
[TBL] [Abstract][Full Text] [Related]
7. Release of photoactivatable drugs from plasmonic nanoparticles for targeted cancer therapy.
Luo YL; Shiao YS; Huang YF
ACS Nano; 2011 Oct; 5(10):7796-804. PubMed ID: 21942498
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin-loaded oligonucleotide conjugated gold nanoparticles: A promising in vivo drug delivery system for colorectal cancer therapy.
Lee CS; Kim H; Yu J; Yu SH; Ban S; Oh S; Jeong D; Im J; Baek MJ; Kim TH
Eur J Med Chem; 2017 Dec; 142():416-423. PubMed ID: 28870452
[TBL] [Abstract][Full Text] [Related]
9. PrP
Go G; Lee CS; Yoon YM; Lim JH; Kim TH; Lee SH
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671292
[TBL] [Abstract][Full Text] [Related]
10. Co-delivery of doxorubicin and aptamer against Forkhead box M1 using chitosan-gold nanoparticles coated with nucleolin aptamer for synergistic treatment of cancer cells.
Khademi Z; Lavaee P; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
Carbohydr Polym; 2020 Nov; 248():116735. PubMed ID: 32919550
[TBL] [Abstract][Full Text] [Related]
11. Porphyran capped gold nanoparticles as a novel carrier for delivery of anticancer drug: in vitro cytotoxicity study.
Venkatpurwar V; Shiras A; Pokharkar V
Int J Pharm; 2011 May; 409(1-2):314-20. PubMed ID: 21376108
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vitro studies of gold nanoparticles loaded with docetaxel.
de Oliveira R; Zhao P; Li N; de Santa Maria LC; Vergnaud J; Ruiz J; Astruc D; Barratt G
Int J Pharm; 2013 Oct; 454(2):703-11. PubMed ID: 23701998
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase triggered size-shrinkable gelatin-gold fabricated nanoparticles for tumor microenvironment sensitive penetration and diagnosis of glioma.
Ruan S; He Q; Gao H
Nanoscale; 2015 Jun; 7(21):9487-96. PubMed ID: 25909483
[TBL] [Abstract][Full Text] [Related]
14. High payload and targeted release of anthracyclines by aptamer-tethered DNA nanotrains - Thermodynamic and release kinetic study.
Pei W; Liu M; Wu Y; Zhao Y; Liu T; Sun B; Liu Y; Wang Q; Han J
Eur J Pharm Sci; 2020 May; 148():105319. PubMed ID: 32205231
[TBL] [Abstract][Full Text] [Related]
15. pH-controlled nucleolin targeted release of dual drug from chitosan-gold based aptamer functionalized nano drug delivery system for improved glioblastoma treatment.
Sathiyaseelan A; Saravanakumar K; Mariadoss AVA; Wang MH
Carbohydr Polym; 2021 Jun; 262():117907. PubMed ID: 33838795
[TBL] [Abstract][Full Text] [Related]
16. Tunable loading of oligonucleotides with secondary structure on gold nanoparticles through a pH-driven method.
Dam DH; Lee H; Lee RC; Kim KH; Kelleher NL; Odom TW
Bioconjug Chem; 2015 Feb; 26(2):279-85. PubMed ID: 25564799
[TBL] [Abstract][Full Text] [Related]
17. Characterization and modulation of drug transport kinetics in K562 c1.6 daunorubicin-resistant cell line.
Jiang XR; Macey MG; Collins PW; Newland AC
Br J Haematol; 1994 Mar; 86(3):547-54. PubMed ID: 8043436
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin-carboxymethyl xanthan gum capped gold nanoparticles: Microwave synthesis, characterization, and anti-cancer activity.
Alle M; G BR; Kim TH; Park SH; Lee SH; Kim JC
Carbohydr Polym; 2020 Feb; 229():115511. PubMed ID: 31826400
[TBL] [Abstract][Full Text] [Related]
19. Tumor-homing, size-tunable clustered nanoparticles for anticancer therapeutics.
Kim J; Lee YM; Kang Y; Kim WJ
ACS Nano; 2014 Sep; 8(9):9358-67. PubMed ID: 25184691
[TBL] [Abstract][Full Text] [Related]
20. Precise engineering of siRNA delivery vehicles to tumors using polyion complexes and gold nanoparticles.
Kim HJ; Takemoto H; Yi Y; Zheng M; Maeda Y; Chaya H; Hayashi K; Mi P; Pittella F; Christie RJ; Toh K; Matsumoto Y; Nishiyama N; Miyata K; Kataoka K
ACS Nano; 2014 Sep; 8(9):8979-91. PubMed ID: 25133608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
